Patients with Acral Lentiginous Melanoma often notice a dark spot or patch on the palms, soles, or under the nails. This spot may change in size, shape, or color over time. It can sometimes be mistaken for a bruise or a fungal infection. In Stage 2, the melanoma is more than 1 mm thick and may have ulceration, which is a breakdown of the skin over the melanoma.

The diagnostic process for ALM involves a thorough physical examination and a biopsy of the suspicious lesion. A biopsy involves removing a small sample of tissue for examination under a microscope. Imaging tests, such as an ultrasound or MRI, may be used to assess the depth of the melanoma and check for any spread to nearby tissues. Blood tests are not typically used to diagnose melanoma but may be part of the overall assessment.

Treatment for Stage 2 Acral Lentiginous Melanoma usually involves surgical removal of the melanoma along with a margin of healthy tissue to ensure complete excision. Depending on the thickness and characteristics of the melanoma, a sentinel lymph node biopsy may be performed to check for cancer spread. Additional treatments, such as immunotherapy or targeted therapy, may be considered based on individual patient factors.

The prognosis for Stage 2 Acral Lentiginous Melanoma varies depending on factors such as the thickness of the melanoma and whether it is ulcerated. Generally, the earlier the melanoma is detected and treated, the better the outcome. Regular follow-up with a healthcare provider is crucial to monitor for any signs of recurrence or spread.

The exact cause of Acral Lentiginous Melanoma is not well understood. Unlike other types of melanoma, ALM is not strongly linked to sun exposure. Genetic factors may play a role, and it is more common in individuals with darker skin tones. However, it can occur in people of any skin color.

Acral Lentiginous Melanoma is relatively rare compared to other types of melanoma, accounting for a small percentage of all melanoma cases. It is more common in people of African, Asian, and Hispanic descent. Despite its rarity, it is the most common type of melanoma found in people with darker skin.

ALM arises from melanocytes located in the skin of the palms, soles, or under the nails. These cells begin to grow uncontrollably, forming a malignant tumor. The pathophysiology involves genetic mutations that lead to the uncontrolled proliferation of melanocytes. The exact mutations can vary, and research is ongoing to better understand these processes.

Preventing Acral Lentiginous Melanoma involves regular self-examinations of the skin, particularly the palms, soles, and nails. Any new or changing lesions should be evaluated by a healthcare provider. While sun protection is important for overall skin health, it is not specifically linked to preventing ALM.

Acral Lentiginous Melanoma is a rare form of skin cancer that appears on the palms, soles, or under the nails. Stage 2 indicates a thicker melanoma that has not spread to lymph nodes. Early detection and treatment are crucial for a favorable outcome. Regular skin checks and awareness of changes in skin lesions are important for early diagnosis.

If you notice a dark spot or patch on your palms, soles, or under your nails that changes in size, shape, or color, it is important to have it evaluated by a healthcare provider. Acral Lentiginous Melanoma is a type of skin cancer that can be treated effectively if caught early. Regular skin checks and awareness of any changes are key to early detection and successful treatment.